Dr. Olajide Williams, Chief of Staff of Neurology at Columbia University, discusses Hip Hop Public Health's campaign to reach and educate communities of color about vaccines.
Drs. Bell and Ader will conduct a feasibility study titled, "Intervention to capture the diagnostic potential of individuals in a group-based learning or clinical environment."
On Monday, the FDA approved a new drug for Alzheimer’s disease—the first in nearly two decades. Biogen’s aducanumab aims to slow the cognitive decline often associated with the disease.
